COMMONS

Genomics and genome-editing examined with experts

29 March 2017

The Science and Technology Committee holds the third session of its genomics and genome editing inquiry, looking at the challenges and opportunities of genome editing in the UK.

Witnesses

Wednesday 29 March 2017, Committee Room 16, Palace of Westminster

At 9.30am

  • Professor Waseem Qasim, Professor in Cell & Gene Therapy, Institute of Child Health
  • Alastair Kent, Director, Genetic Alliance UK
  • Dr Kathy Niakan, Group Leader, The Francis Crick Institute

At 10.20am

  • Dr Andy Greenfield, Programme Leader, Medical Research Council's Harwell Institute
  • Robin Lovell-Badge, Senior Group Leader, The Francis Crick Institute
  • James Lawford Davies, Partner, Hempsons
  • Philippa Taylor, Head of Public Policy, Christian Medical Fellowship

Purpose of the session

Two panels of experts take part in the session. The first panel looks at the practical challenges of undertaking research into gene editing, and how this translates into NHS treatment while taking account of patient perspectives. The second panel looks in greater detail at the ethical, regulatory and international issues surrounding innovative genome editing techniques.

 Further information

Image: iStockphoto

More news on: Parliament, government and politics, Health services and medicine, Medicine, Science and technology, Parliament, House of Commons news, Commons news, Committee news, Science, Genetics

Share this page